HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

(64)Cu-DOTA-vMIP-II

a PET imaging agent for chemokine receptors

Also Known As:

64Cu-DOTA-vMIP-II

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Liu, Yongjian: 2 articles (01/2021 - 07/2013)
2.	Baba, Osamu: 1 article (01/2021)
3.	Chevigne, Andy: 1 article (01/2021)
4.	Detering, Lisa: 1 article (01/2021)
5.	Elvington, Andrew: 1 article (01/2021)
6.	Heo, Gyu Seong: 1 article (01/2021)
7.	Huang, Li-Hao: 1 article (01/2021)
8.	Luehmann, Hannah: 1 article (01/2021)
9.	Randolph, Gwendalyn J: 1 article (01/2021)
10.	Sultan, Deborah: 1 article (01/2021)

Related Diseases

1.	Atherosclerosis 07/01/2013 - "(64)Cu-DOTA-vMIP-II was proven a sensitive and useful PET imaging probe for the detection of 8 up-regulated chemokine receptors in a model of injury-accelerated atherosclerosis."
2.	Disease Progression 01/01/2021 - "Using fluorescence-tagged vMIP-II tracer, competitive receptor blocking with CXCR4 antagonists, endothelial-specific Cre-mediated deletion of CXCR4, CXCR4-specific tracer 64Cu-DOTA-FC131, and CXCR4 staining during disease progression and regression, we show endothelial cell expression of CXCR4 is a key target of 64Cu-DOTA-vMIP-II imaging. "

Related Drugs and Biologics

1.	Chemokine Receptors
2.	vMIP-II